Integration of a transposon Tn1-encoded inhibitor-resistant β-lactamase gene, blaTEM-67 from Proteus mirabilis, into the Escherichia coli chromosome

被引:25
作者
Naas, T
Zerbib, M
Delphine, GL
Nordmann, P
机构
[1] Hop Bicetre, Serv Bacteriol Virol, Assistance Publ Hop Paris, Fac Med Paris Sud, F-94275 Le Kremlin Bicetre, France
[2] Hop Foch, Unite Hyg, F-92151 Suresnes, France
关键词
D O I
10.1128/AAC.47.1.19-26.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Proteus mirabilis NEL-1 was isolated from a urine sample of a patient hospitalized in a long-term care facility. Strain NEL-1 produced a beta-lactamase with a pI of 5.2 conferring resistance to amoxicillin and amoxicillin-clavulanic acid. Sequencing of a PCR amplicon by using TEM-specific primers revealed a novel bla(TEM) gene, bla(TEM-67). TEM-67 was an IRT-1-like TEM derivative related to TEM-65 (Lys39, Cys244) with an additional Leu21IIe amino acid substitution in the leader peptide. The biochemical properties of TEM-67 were equivalent to those described for TEM-65. Analysis of sequences surrounding bla(TEM-67) revealed that it was located on a transposon, Tn1, which itself was located on a 48-kb non-self-transferable plasmid, pANG-1. Electroporation of plasmid pANG-1 into Escherichia coli DH10B resulted in the integration of bla(TEM-67) into the chromosome, whereas it remained episomal in the P. mirabilis CIP103181 reference strain. Further characterization of pANG-1 revealed the presence of two identical sequences on both sides of Tn1 that contained an IS26 insertion sequence followed by a novel colicin gene, colZ, which had 20% amino acid identity with other colicin genes. The characterization of this novel TEM derivative provides further evidence for the large diversity of plasmid-encoded beta-lactamases produced in P. mirabilis and for their spread to other enterobacterial species through transposable-element-mediated events.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 43 条
[1]   A STANDARD NUMBERING SCHEME FOR THE CLASS-A BETA-LACTAMASES [J].
AMBLER, RP ;
COULSON, AFW ;
FRERE, JM ;
GHUYSEN, JM ;
JORIS, B ;
FORSMAN, M ;
LEVESQUE, RC ;
TIRABY, G ;
WALEY, SG .
BIOCHEMICAL JOURNAL, 1991, 276 :269-270
[2]   Diversity of TEM mutants in Proteus mirabilis [J].
Bonnet, R ;
De Champs, C ;
Sirot, D ;
Chanal, C ;
Labia, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2671-2677
[3]   Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 beta-lactamase produced by Proteus mirabilis strains [J].
Bret, L ;
Chanal, C ;
Sirot, D ;
Labia, R ;
Sirot, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) :183-191
[4]   Inhibitor-resistant TEM β-lactamases:: phenotypic, genetic and biochemical characteristics [J].
Chaïbi, EB ;
Sirot, D ;
Paul, G ;
Labia, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :447-458
[5]   Prevalence of β-lactamases among 1,072 clinical strains of Proteus mirabilis:: a 2-year survey in a French hospital [J].
Chanal, C ;
Bonnet, R ;
De Champs, C ;
Sirot, D ;
Labia, R ;
Sirot, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1930-1935
[6]   VARIATIONS BETWEEN THE NUCLEOTIDE-SEQUENCES OF TN1, TN2, AND TN3 AND EXPRESSION OF BETA-LACTAMASE IN PSEUDOMONAS-AERUGINOSA AND ESCHERICHIA-COLI [J].
CHEN, ST ;
CLOWES, RC .
JOURNAL OF BACTERIOLOGY, 1987, 169 (02) :913-916
[7]   Infections in the elderly [J].
Crossley, KB ;
Peterson, PK .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (02) :209-214
[8]   OXA-14, ANOTHER EXTENDED-SPECTRUM VARIANT OF OXA-10 (PSE-2) BETA-LACTAMASE FROM PSEUDOMONAS-AERUGINOSA [J].
DANEL, F ;
HALL, LMC ;
GUR, D ;
LIVERMORE, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) :1881-1884
[9]   Clinical relevance of Proteus mirabilis in hospital patients:: a two year survey [J].
de Champs, C ;
Bonnet, R ;
Sirot, D ;
Chanal, C ;
Sirot, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (04) :537-539
[10]  
GALAS DJ, 1989, MOBILE DNA, P109